Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman Disease

Castleman disease (CD) is a rare lymphoproliferative disorder. The mechanistic target of rapamycin (mTOR) pathway is a key regulator of various cellular functions, which may be related with the potential mechanisms of CD occurrence. We retrospectively collected the clinical information of 60 CD pati...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Siyu Qian, Mengjie Ding, Huting Hou, Zeyuan Wang, Jieming Zhang, Yue Zhang, Meng Dong, Linan Zhu, Guannan Wang, Wencai Li, Xudong Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-05-01
Colecção:	Frontiers in Immunology
Assuntos:	Castleman disease classifications prognosis mTOR pathway thrombocytopenia
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.899073/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!